Chemical Structure : NXT629
CAS No.: 1454925-59-7
Catalog No.: PC-72656Not For Human Use, Lab Use Only.
NXT629 (NXT-629) is a potent, selective PPARα antagonist with IC50 of 78 nM, no effect against PPARδ and PPARγ (IC50>30 uM).
Packing | Price | Stock | Quantity |
---|---|---|---|
2 mg | $258 | In stock | |
5 mg | $458 | In stock | |
10 mg | $728 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
NXT629 (NXT-629) is a potent, selective PPARα antagonist with IC50 of 77 nM (human PPARα), no effect against PPARδ and PPARγ (IC50>30 uM).
NXT629 inhibited agonist-induced transcription of PPARα-regulated genes, demonstrating target engagement in chronic lymphocytic leukemia (CLL) cells.
NXT629 induced apoptosis of CLL cells even in the presence of a protective microenvironment.
NXT629 reduces the number of chronic leukemia cells undergoing cell division with IC50 of 9.6 uM.
NXT629 reduces CLL tumor burden delays disease progression of CLL in CLL mouse model.
M.Wt | 609.789 | |
Formula | C35H39N5O3S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
100 mM in DMSO (60.9 mg/mL) |
|
Chemical Name/SMILES |
N-(6-(4-(3-(1-(4-(tert-Butyl)benzyl)-4-ethyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)propyl)phenyl)pyridin-3-yl)benzenesulfonamide |
1. Messmer D, et al. Mol Med. 2015 Jun 9;21(1):410-9.
2. Stebbins KJ, et al. Eur J Pharmacol. 2017 Aug 15;809:130-140.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright